Overexpression and Purification of DNA Topoisomerase I from Yeast

Methods in Molecular Biology

Volumn 94, Issue , 1999, Pages 179-186

  Bjornsti, Mary Ann ^a   Fertala, Jolanta ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adenine Sulfate; Ammonium Sulfate; Phosphocellulose Column; Solid Ammonium Sulfate; Top1 Protein

Indexed keywords

DNA TOPOISOMERASE;

ARTICLE; ENZYMOLOGY; GENETIC TRANSFORMATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PLASMID; SACCHAROMYCES CEREVISIAE;

DNA TOPOISOMERASES, TYPE I; PLASMIDS; SACCHAROMYCES CEREVISIAE; TRANSFORMATION, GENETIC;

MLCS; MLOWN;

EID: 4444285326     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1385/1-59259-259-7:179     Document Type: Chapter

References (27)

1. Wang, J. C. (1996) DNA topoisomerases. Ann. Rev. Biochem. 65, 635–692.
2. Chen, A. and Liu, L. F. (1994) DNA topoisomerases: essential enzymes and lethal targets. Ann. Rev. Pharmacol. Toxicol. 34, 191–218.
3. Bjornsti, M.-A., Knab, A. M., and Benedetti, P. (1994) Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin. Cancer Chemother. Pharmacol. 34, S1–S5.
4. Benedetti, P., Fiorani, P., Capuani, L., and Wang, J. C. (1993) Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine. Cancer Res. 53, 4343–4348.
5. Bjornsti, M.-A., Benedetti, P., Viglianti, G. A., and Wang, J. C. (1989) Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. Cancer Res. 49, 6318–6323.
6. Bjornsti, M.-A. and Wang, J. C. (1987) Expression of Yeast DNA Topoisomerase I can Complement a Conditional-lethal DNA Topoisomerase I Mutation in Esherichia coli. Proc. Natl. Acad. Sci. USA 84, 8971–8975.
7. Bjornsti, M.-A. (1991) DNA topoisomerases. Curr. Opin. Struct. Biol. 1, 99–103.
8. Champoux, J. (1990) Mechanistic aspects of type-I topoisomerases, in DNA Topology and its Biological Effects (Cozzarelli, N. R. and Wang, J. C., eds.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 217–242.
9. Christiansen, K., Svejstrup, A. B. D., Andersen, A. H., and Westergaard, O. (1993) Eukaryotic topoisomerase I-mediated cleavage requires bipartite DNA interaction. J. Biol. Chem. 268, 9690–9701.
10. Eng, W.-K., Pandit, S. D., and Sternglanz, R. (1989) Mapping of the Active Site Tyrosine of Eukaryotic DNA Topoisomerase I. J. Biol. Chem. 264, 13,373–13,376.
11. Gupta, M., Fujimori, A., and Pommier, Y. (1995) Eukaryotic DNA topoisomerase I. BBA 1262, 1–14.
12. Knab, A. M., Fertala, J., and Bjornsti, M.-A. (1993) Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants. J. Biol. Chem. 268, 22,322–22,330.
13. Knab, A. M., Fertala, J., and Bjornsti, M.-A. (1995) A camptothecin-resistant DNA toposiomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons. J. Biol. Chem. 270, 6141–6148.
14. Kubota, N., Kanazawa, F., Nishio, K., Takeda, Y., Ohmori, T., Fujiwara, T., et al. (1992) Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line. Biochem. Biophys. Res. Comm. 188, 571–577.
15. Levin, N. A., Bjornsti, M.-A., and Fink, G. R. (1993) A novel mutation in DNA topoisomerase I of yeast causes DNA damage and RAD9-dependent cell cycle arrest. Genetics 133, 799–814.
16. Lue, N., Sharma, A., Mondragon, A., and Wang, J. C. (1995) A 26 kDa yeast DNA topoisomerase I fragment—crystallographic structure and mechanistic implications. Structure 3, 1315–1322.
17. Pommier, Y. (1996) Eukaryotic DNA topoisomerase I—genome gatekeeper and its intruders, camptothecins. Semin. Oncol. 23, 3–10.
18. Stewart, L., Ireton, G. C., and Champoux, J. J. (1996) The domain organization of human topoisomerase I. J. Biol. Chem. 271, 7602–7608.
19. Stewart, L., Ireton, G. C., Parker, L. H., Madden, K. R., and Champoux, J. J. (1996) Biochemical and biophysical analysis of recombinant forms of human DNA topoisomerase I. J. Biol. Chem. 271, 7593–7601.
20. Tanizawa, A., Kohn, K. W., Kohlhagen, G., Leteurte, F., and Pommier, Y. (1995) Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives. Biochemistry 34, 7200–7206.
21. Holm, C., Goto, T., Wang, J. C., and Botstein, D. (1985) DNA topoisomerase II is required at the time of mitosis in yeast. Cell 41, 553–563.
22. Goto, T. and Wang, J. C. (1985) Cloning of yeast TOP1, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II. Proc. Natl. Acad. Sci. USA 82, 7178–7182.
23. Castano, I. B., Heathpagliuso, S., Sadoff, B. U., Fitzhugh, D. J., and Christman, M. F. (1996) A novel family of Trf (DNA topoisomerase L-related function) genes required for proper nuclear segregation. Nucleic Acids Res. 24, 2404–2410.
24. G . Mol. Cell. Biol. 4, 2467–2478.
25. Lindsley, J. E. and Wang, J. C. (1991) Proteolysis patterns of epitopically labeled yeast DNA topoisomerase II suggest an allosteric transition in the enzyme induced by ATP binding. Proc. Natl. Acad. Sci. USA 88, 10,485–10,489.
26. Kaiser, C., Michaelis, S., and Mitchell, A. (1994) Methods in Yeast Genetics: A Laboratory Course Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, p. 234.
27. Rose, M. D., Winston, F., and Hieter, P. (1990) Methods in Yeast Genetics: A Laboratory Course Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, p. 198.